AAIC 2025 Abstract
Longitudinal analysis of human plasma biomarkers for Alzheimer's disease: Phosphorylated Tau‐217, Phosphorylated Tau‐181, and Glial fibrillation acidic protein
By Maya Rae N. Mugosa, Jefferson W. Kinney, Lorenzo Gabriel Pasia, Show 2 more authorsAaron R. Ritter
Study in peopleBiomarkers
Abstract
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease affecting memory and cognitive processes, making it increasingly difficult for individuals to perform daily tasks as the disease progresses. Early diagnosis and tracking of disease progression is crucial for optimal treatment and support.
